Medical Cannabis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Medical Cannabis stocks.

Recent Signals

Date Stock Signal Type
2021-03-03 ACB Stochastic Buy Signal Bullish
2021-03-03 CGC Evening Star Bearish
2021-03-03 CGC Fell Below 50 DMA Bearish
2021-03-03 CLVR Fell Below 20 DMA Bearish
2021-03-03 HUGE 50 DMA Resistance Bearish
2021-03-03 IGC Fell Below 50 DMA Bearish
2021-03-03 KERN Fell Below 200 DMA Bearish
2021-03-03 KERN Fell Below 50 DMA Bearish
2021-03-03 MJ Stochastic Buy Signal Bullish
2021-03-03 MJJ 50 DMA Support Bullish
2021-03-03 MJJ Narrow Range Bar Range Contraction
2021-03-03 MJO Fell Below 50 DMA Bearish
2021-03-03 MJO Narrow Range Bar Range Contraction
2021-03-03 TLRY Narrow Range Bar Range Contraction

Recent News for Medical Cannabis Stocks

Date Stock Title
Mar 3 TLRY Cannabis ETF (MSOS) On a High, Reaches $1B AUM Milestone
Mar 3 ACB Tilray Beats Canopy Growth and Aurora Cannabis to Profitability
Mar 3 TLRY Tilray Beats Canopy Growth and Aurora Cannabis to Profitability
Mar 3 TLRY The 10 Best Marijuana Stocks in February
Mar 3 OGI The 10 Best Marijuana Stocks in February
Mar 3 TLRY Should You Buy Tilray Stock Before the Aphria Merger?
Mar 2 TLRY Detroit's Mortgage Giants Rocket Higher Amid Latest WallStreetBets-Sparked Short Squeeze
Mar 2 CGC More States Consider Legalizing Recreational Use of Marijuana. Pot Stocks Are Gaining.
Mar 2 ACB More States Consider Legalizing Recreational Use of Marijuana. Pot Stocks Are Gaining.
Mar 2 MJ More States Consider Legalizing Recreational Use of Marijuana. Pot Stocks Are Gaining.
Mar 2 TLRY More States Consider Legalizing Recreational Use of Marijuana. Pot Stocks Are Gaining.
Mar 2 CGC Canopy Growth Corporation (CGC) Soars 6.1%: Is Further Upside Left in the Stock?
Mar 2 CGC Canopy Growth vs Tilray: How Do They Compete?
Mar 2 TLRY Canopy Growth vs Tilray: How Do They Compete?
Mar 2 CGC Marijuana Stocks: Canopy Growth Launches CBD Beverages In The U.S.
Mar 2 TLRY Marijuana Stocks: Canopy Growth Launches CBD Beverages In The U.S.
Mar 2 ACB Marijuana Stocks: Canopy Growth Launches CBD Beverages In The U.S.
Mar 2 CGC Canopy Growth introduces CBD beverage brand Quatreau in U.S.
Mar 2 CLVR Clever Leaves Receives Largest 2021 Production Quotas from the Colombian Government
Mar 2 CGC Canopy Growth Launches CBD Beverage Brand Quatreau in the U.S.

Medical cannabis, or medical marijuana, is cannabis and cannabinoids that are recommended by doctors for their patients. The use of cannabis as medicine has not been rigorously tested due to production restrictions and other governmental regulations. Limited evidence suggests that cannabis can reduce nausea and vomiting during chemotherapy, improve appetite in people with HIV/AIDS, and reduce chronic pain and muscle spasms.Short-term use increases the risk of minor and major adverse effects. Common side effects include dizziness, feeling tired, vomiting, and hallucinations. Long-term effects of cannabis are not clear. Concerns include memory and cognition problems, risk of addiction, schizophrenia in young people, and the risk of children taking it by accident.The Cannabis plant has a history of medicinal use dating back thousands of years in many cultures. A number of medical organizations have requested removal of cannabis from the list of Schedule I controlled substances, followed by regulatory and scientific review. Others oppose its legalization, such as the American Academy of Pediatrics.Medical cannabis can be administered through a variety of methods, including capsules, lozenges, tinctures, dermal patches, oral or dermal sprays, cannabis edibles, and vaporizing or smoking dried buds. Synthetic cannabinoids are available for prescription use in some countries, such as dronabinol and nabilone. Countries that allow the medical use of whole-plant cannabis include Australia, Canada, Chile, Colombia, Germany, Greece, Israel, Italy, the Netherlands, Peru, Poland, Portugal, and Uruguay. In the United States, 33 states and the District of Columbia have legalized cannabis for medical purposes, beginning with the passage of California's Proposition 215 in 1996. Although cannabis remains prohibited for any use at the federal level, the Rohrabacher–Farr amendment was enacted in December 2014, limiting the ability of federal law to be enforced in states where medical cannabis has been legalized.

More about Medical Cannabis
Browse All Tags